FR2875512B1 - Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation - Google Patents

Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation

Info

Publication number
FR2875512B1
FR2875512B1 FR0409862A FR0409862A FR2875512B1 FR 2875512 B1 FR2875512 B1 FR 2875512B1 FR 0409862 A FR0409862 A FR 0409862A FR 0409862 A FR0409862 A FR 0409862A FR 2875512 B1 FR2875512 B1 FR 2875512B1
Authority
FR
France
Prior art keywords
biopuce
metastatic
diagnostic
kit
mammary tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0409862A
Other languages
English (en)
Other versions
FR2875512A1 (fr
Inventor
Valerie Chabaud
Incan Chantal D
Vidal Valerie Sylvain
Veronique Vidal
Marie Agier
Yves Jean Bignon
Christian Pradeyrol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnogene S A
Original Assignee
Diagnogene S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnogene S A filed Critical Diagnogene S A
Priority to FR0409862A priority Critical patent/FR2875512B1/fr
Priority to PCT/FR2005/002308 priority patent/WO2006032769A1/fr
Publication of FR2875512A1 publication Critical patent/FR2875512A1/fr
Application granted granted Critical
Publication of FR2875512B1 publication Critical patent/FR2875512B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0409862A 2004-09-17 2004-09-17 Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation Expired - Fee Related FR2875512B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0409862A FR2875512B1 (fr) 2004-09-17 2004-09-17 Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation
PCT/FR2005/002308 WO2006032769A1 (fr) 2004-09-17 2005-09-19 Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammmaire, procede et kit d'utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409862A FR2875512B1 (fr) 2004-09-17 2004-09-17 Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation

Publications (2)

Publication Number Publication Date
FR2875512A1 FR2875512A1 (fr) 2006-03-24
FR2875512B1 true FR2875512B1 (fr) 2011-02-04

Family

ID=34948818

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0409862A Expired - Fee Related FR2875512B1 (fr) 2004-09-17 2004-09-17 Biopuce de diagnostic du caractere metastatique ou localise d'une tumeur mammaire, procede et kit d'utilisation

Country Status (2)

Country Link
FR (1) FR2875512B1 (fr)
WO (1) WO2006032769A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG139563A1 (en) * 2006-07-13 2008-02-29 Shimadzu Corp Diagnostic biomolecules
EP4363618A1 (fr) 2021-06-30 2024-05-08 University of Limerick Signature génétique pour l'identification de l'atteinte des ganglions lymphatiques chez les patients atteints de cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE270712T1 (de) * 1995-03-17 2004-07-15 Wayne John Cancer Inst Nachweis von melanomenmetastasen unter verwendung eines mehrfachmarker-tests
US20030158109A1 (en) * 2000-11-13 2003-08-21 Klaus Giese Metastatic breast and colon cancer regulated genes
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
FR2833968A1 (fr) * 2001-12-20 2003-06-27 Ct Medico Chirurgical De Tronq Biopuces thematiques, comportant des modules de recherche associes ou couples, leur procede de preparation, et leurs applications
US20040191783A1 (en) * 2003-03-31 2004-09-30 Guy Leclercq Low density micro-array analysis in human breast cancer
JP4579246B2 (ja) * 2003-09-24 2010-11-10 オンコセラピー・サイエンス株式会社 乳癌を診断する方法

Also Published As

Publication number Publication date
WO2006032769A1 (fr) 2006-03-30
FR2875512A1 (fr) 2006-03-24

Similar Documents

Publication Publication Date Title
GB0418542D0 (en) Integrated biosensor and simulation system for diagnosis and therapy
EP1589933A4 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
DE502005002436D1 (de) Endochirurgischer bergebeutel für die aufnahme von körpergewebe oder -flüssigkeit
EP1720450A4 (fr) Appareil pour actes medicaux et ou simulation
DE60206999D1 (de) Durchflussgerät für die Zerstörung von Mikroorganismen in Fluiden mittels Ultraschalls
EP1782315A4 (fr) Pronostic de patients atteints d'un cancer du sein
DE602005011660D1 (de) Ultraschallsonde und Ultraschallgerät
EP1553912A4 (fr) Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
DE60315135D1 (de) Therapiesonde
DE602004024630D1 (de) Ultraschalldiagnosegerät
EP1578380A4 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate
DE602004023991D1 (de) Ultraschalldiagnosegerät
NO20023402D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av prostatakreft
EP1554982A4 (fr) Appareil ultrasonographique
DE60331861D1 (de) Ultraschallverfahren und ultraschallgerät
BRPI0311233A2 (pt) diagnóstico de carcinoma hepatocelular
HUP0400904A2 (en) Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
DE602004000360D1 (de) Kontinuierlicher Mischer sowie Betriebsverfahren des Mischers
DE10292329D2 (de) Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
EP1425575A4 (fr) Nouveau marqueur du cancer et ses utilisations dans le diagnostic du cancer
DE60226217D1 (de) Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper
ITBO20030171A1 (it) Attrezzo ginnico per esercizi di deambulazione e corsa.
GB0326578D0 (en) Cancer diagnosis and therapy
MA26071A1 (fr) Compteur volumetrique de fluide
EP1825003A4 (fr) Identification et utilisation de marqueurs pronostiques et predictifs dans le traitement du cancer

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120531